Pascal Soriot, AstraZeneca CEO (Raphael Lafargue/Abaca/Sipa USA; Sipa via AP Images)
February 16, 2021 09:19 AM EST
People

As­traZeneca's Pas­cal So­ri­ot picks up $21.5M pay pack­age in 2020, a big haul in year marked by Covid-19 shot de­vel­op­ment

Kyle Blankenship

As­traZeneca’s 2020 was one for the books as the British drug­mak­er kept up a fer­vid pace with part­ner Ox­ford Uni­ver­si­ty to de­vel­op their ade­n­ovirus-based Covid …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times